LP-0200

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameLP-0200

Drug Alias NameLP-0200LP 0200

ClassificationSmall molecules

Mechanisms of ActionInterleukin 17A modulators

TargetsInterleukin 17A

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLeo Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesLeo Pharma Inc

Inactive CompaniesN/A

Active IndicationsPsoriasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A